Xconomy National

Archives

by in

Entry	Author	Date	Location
Five Myths You’ll Hear This Week at the JP Morgan Healthcare Conference	Luke Timmerman	01/09/12	National
PacBio Slashes 28 Percent of Its Workforce to Conserve Cash	Wade Roush	09/20/11	San Francisco
Vivus Adds $45.8M	Luke Timmerman	08/23/11	San Francisco
Exclusive: Pathway Medical Technologies To Be Acquired by Bayer’s Medrad Unit for $125M	Luke Timmerman	08/19/11	Seattle
Time to Cure Cancer or Stash Cash Under the Mattress?	Luke Timmerman	08/15/11	National
OncoGenex Drops on Trial Delay	Luke Timmerman	08/05/11	Seattle
PacBio Hits Goal in Debut Quarter With New DNA Sequencer, Stock Tanks Anyway	Luke Timmerman	08/04/11	San Francisco
Complete Genomics Stock Falls on Sales Decline, as Sequencing Gets Cheaper	Luke Timmerman	08/04/11	San Francisco
Illumina Sales Climb 36%, Profits Flat	Luke Timmerman	07/26/11	San Diego
SonoSite Reports Narrow Q2 Loss	Luke Timmerman	07/25/11	Seattle
Insider Trader Pleads Guilty in SeaGen Case	Luke Timmerman	07/12/11	Seattle
Hutch, Sangamo Win $20M HIV Grant	Luke Timmerman	07/11/11	Seattle
SeaGen Preserves Science Culture, Dendreon Sways Medicare, NanoString’s Financing, & More Seattle-Area Life Sciences News	Luke Timmerman	07/07/11	Seattle
Impel Snags $750K Grant	Luke Timmerman	06/24/11	Seattle
Allozyne Acquires Poniard Pharmaceuticals, Finds Backdoor Route to NASDAQ	Luke Timmerman	06/22/11	Seattle
Alder Gets $15M From Bristol	Luke Timmerman	06/20/11	Seattle
Aveo Gets $100M in Stock Offering	Luke Timmerman	06/15/11	Boston
Ambit Raises $30M Venture Round, After Pulling Plug on IPO	Luke Timmerman	06/10/11	San Diego
Adaptive TCR, a Fred Hutch Spinoff, Snags $5.8M to Take Immune System Profiling Up a Notch	Luke Timmerman	06/06/11	Seattle
The Quest For Biotech Independence: Maybe It Isn’t So Quixotic After All	Luke Timmerman	06/06/11	National
Anthera Raises $47M	Luke Timmerman	06/03/11	San Francisco
Complete Genomics Adds $69M	Luke Timmerman	05/27/11	San Francisco
Rigel Pockets $130M in Financing, Seeks To Pick up Pfizer’s Ball and Run With it	Luke Timmerman	05/26/11	San Francisco
How to Make Money in Biotech With No Hope of Going Public, Slim Odds of Getting Acquired	Luke Timmerman	05/23/11	National
ImmunoGen Grabs $84M	Luke Timmerman	05/20/11	Boston
Celldex Raises $31.5M, Stock Drops	Luke Timmerman	05/18/11	Boston
Marina Biotech Adds $6.9M	Luke Timmerman	05/17/11	Seattle
Will Biotech Ever Again Captivate the Public Imagination, Like Facebook or LinkedIn?	Luke Timmerman	05/16/11	National
Varian Invests $15M in Augmenix	Luke Timmerman	05/12/11	Boston
SpringLeaf Snags $15M for New Self-Injection System for Biotech Drugs	Luke Timmerman	05/12/11	Boston
Page 1 of 11	next page »